Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis
Xue Lyu,* Zhe Zhang,* Xia Liu,* Li Geng, Muhan Zhang, Baisui Feng Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, People’s Republic of China*These authors contributed equally to this workCorrespondence: Baisui...
Main Authors: | Lyu X, Zhang Z, Liu X, Geng L, Zhang M, Feng B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-05-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/prediction-and-verification-of-potential-therapeutic-targets-for-non-r-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01) -
Identified potential biomarkers may predict primary nonresponse to infliximab in patients with ulcerative colitis
by: Jixiang Zhang, et al.
Published: (2022-11-01) -
Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis
by: Gabriela Maria Henz Giovelli, et al.
Published: (2023-12-01) -
Short-Term Response to Infliximab in Rheumatoid Pattern Polyarthropathy Complicating Ulcerative Colitis
by: ilke Coskun Benlidayi, et al.
Published: (2015-12-01) -
Protracted fever after infliximab induction therapy in a patient with ulcerative colitis (clinical case)
by: E. Yu. Chashkova, et al.
Published: (2022-12-01)